Rabi et al. [71] treated androgen-refractory human prostate cancer cells PC-3 with BA, and the cell line they used expressed high constitutive NF-κB, which partly led to the chemoresistance of androgen-refractory prostate cancer. The gene discussed is NFKB1; the disease is prostate cancer.